Advances in fatty acid metabolism in cancer patients with cachexia

doi:10.3877/cma.j.issn.1674-3946.2023.01.027

Abstract

Abstract:

Cancer is expected to become the number one killer of human health. In recent years，there has been a surge in research on the nutritional metabolism of cancer，including the effects of nutrients such as glucose，amino acids，and fatty acids on the proliferation and spread of cancer. Cachexia is a key factor affecting the prognosis of cancer. About 80% of cancer patients suffer from cachexia，which leads to the failure of cancer treatment. At present，there are still many clinical studies on drug therapy and dietary therapy for cachexia. This review mainly reviews the research progress of cachexia fatty acid metabolism in gastric cancer through the effects of fatty acids on cancer cell proliferation and metastasis，cachexia fatty acid-related drugs，and dietary therapy.

Key words: Cachexia, Fatty Acid

Yu Liu, Meng Wang. Advances in fatty acid metabolism in cancer patients with cachexia[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(01): 105-109.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhpwkssxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3946.2023.01.027

https://zhpwkssxzz.cma-cmc.com.cn/EN/Y2023/V17/I01/105

Figures/Tables 1

References 54

[21]	Ladanyi A，Mukherjee A，Kenny HA，et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis［J］. Oncogene，2018，37（17）：2285-2301.
[22]	Watt MJ，Clark AK，Selth LA，et al. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer［J］. Sci Transl Med，2019，11（478）：eaau5758.
[23]	Bergers G，Fendt SM. The metabolism of cancer cells during metastasis［J］. Nat Rev Cancer，2021，21（3）：162-180.
[24]	Pan J，Dai Q，Zhang T，et al. Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway［J］. Cancer Cell Int，2019，19：69.
[25]	Peck B，Schug ZT，Zhang Q，et al. Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments［J］. Cancer Metab，2016，4：6.
[26]	Peck B，Schulze A. Lipid desaturation - the next step in targeting lipogenesis in cancer？［J］. FEBS J，2016，283（15）：2767-2778.
[27]	Kikuchi K，Tsukamoto H. Stearoyl-CoA desaturase and tumorigenesis［J］. Chem Biol Interact，2020，316：108917.
[28]	Presler M，Wojtczyk-Miaskowska A，Schlichtholz B，et al. Increased expression of the gene encoding stearoyl-CoA desaturase 1 in human bladder cancer［J］. Mol Cell Biochem，2018，447（1-2）：217-224.
[29]	Luis G，Godfroid A，Nishiumi S，et al. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1（SCD1）in cancer cells and Fatty Acid Biding Protein-4（FABP4）in tumor microenvironment promote tumor recurrence［J］. Redox Biol，2021，43：102006.
[30]	Wang C，Shi M，Ji J，et al. Stearoyl-CoA desaturase 1（SCD1）facilitates the growth and anti-ferroptosis of gastric cancer cells and predicts poor prognosis of gastric cancer［J］. Aging（Albany NY），2020，12（15）：15374-15391.
[31]	Petruzzelli M，Schweiger M，Schreiber R，et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia［J］. Cell Metabolism，2014，20（3）：433-447.
[32]	Cohen P，Levy JD，Zhang Y，et al. Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch［J］. Cell，2014，156（1-2）：304-316.
[33]	Peng WQ，Xiao G，Li BY，et al. l-Theanine Activates the Browning of White Adipose Tissue Through the AMPK/α-Ketoglutarate/Prdm16 Axis and Ameliorates Diet-Induced Obesity in Mice［J］. Diabetes，2021，70（7）：1458-1472.
[34]	Simopoulos AP. An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity［J］. Nutrients，2016，8（3）：128.
[35]	Briscoe CP，Tadayyon M，Andrews JL，et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids［J］. J Biol Chem，2003，278（13）：11303-11311.
[36]	Hirasawa A，Tsumaya K，Awaji T，et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120［J］. Nat Med，2005，11（1）：90-94.
[37]	Freitas RDS，Campos MM. Protective Effects of Omega-3 Fatty Acids in Cancer-Related Complications［J］. Nutrients，2019，11（5）：945.
[38]	Freitas RDS，Muradás TC，Dagnino APA，et al. Targeting FFA1 and FFA4 receptors in cancer-induced cachexia［J］. Am J Physiol Endocrinol Metab，2020，319（5）：E877-E892.
[39]	Hanai N，Terada H，Hirakawa H，et al. Prospective randomized investigation implementing immunonutritional therapy using a nutritional supplement with a high blend ratio of ω-3 fatty acids during the perioperative period for head and neck carcinomas［J］. Jpn J Clin Oncol，2018，48（4）：356-361.
[40]	Manson JE，Cook NR，Lee IM，et al. Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer［J］. N Engl J Med，2019，380（1）：23-32.
[41]	Bai D，Wu Y，Deol P，et al. Palmitic acid negatively regulates tumor suppressor PTEN through T366 phosphorylation and protein degradation［J］. Cancer Lett，2021，496：127-133.
[42]	Pascual G，Domínguez D，Elosúa-Bayes M，et al. Dietary palmitic acid promotes a prometastatic memory via Schwann cells［J］. Nature，2021，599（7885）：485-490.
[43]	Johns N，Stephens NA，Fearon KC. Muscle wasting in cancer［J］. Int J Biochem Cell Biol，2013，45（10）：2215-2229.
[44]	Kanarek N，Petrova B，Sabatini DM. Dietary modifications for enhanced cancer therapy［J］. Nature，2020，579（7800）：507-517.
[45]	Brandhorst S，Choi IY，Wei M，et al. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration，Enhanced Cognitive Performance，and Healthspan［J］. Cell Metabolism，2015，22（1）：86-99.
[46]	Gallagher EJ，LeRoith D. Minireview：IGF，Insulin，and Cancer［J］. Endocrinology，2011，152（7）：2546-2551.
[47]	Weber DD，Aminazdeh-Gohari S，Kofler B. Ketogenic diet in cancer therapy［J］. Aging（Albany NY），2018，10（2）：164-165.
[48]	Allen BG，Bhatia SK，Anderson CM，et al. Ketogenic diets as an adjuvant cancer therapy：History and potential mechanism［J］. Redox Biol，2014，2：963-970.
[49]	Torrence ME，Manning BD. Nutrient sensing in cancer［J］. Ann Rev Cancer Biol，2018，2：251-269.
[50]	Fruman DA，Chiu H，Hopkins BD，et al. The PI3K Pathway in Human Disease［J］. Cell，2017，170（4）：605-635.
[51]	Hopkins BD，Pauli C，Du X，et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors［J］. Nature，2018，560（7719）：499-503.
[52]	Hao JW，Wang J，Guo H，et al. CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis［J］. Nat Communication，2020，11（1）：4765.
[53]	Cao W，Yang W，Fan R，et al. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway［J］. Tumour Biol，2014，35（2）：1287-1295.
[54]	俞发荣，李建军，Yu Xin，等. 不饱和脂肪酸对人胃癌细胞PI3K-Akt信号通路中相关基因表达的影响［J］.生态科学，2019，38（06）：60-63.
[1]	Bray F，Ferlay J，Soerjomataram I，et al. Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin，2018，68（6）：394-424.
[2]	Argilés JM，Stemmler B，López-Soriano FJ，et al. Inter-tissue communication in cancer cachexia［J］. Nat Rev Endocrinol，2018，15（1）：9-20.
[3]	Fearon K，Strasser F，Anker SD，et al. Definition and classification of cancer cachexia：an international consensus［J］. Lancet Oncol，2011，12（5）：489-495.
[4]	Porporato PE. Understanding cachexia as a cancer metabolism syndrome［J］. Oncogenesis，2016，5（2）：e200.
[5]	Maan M，Peters JM，Dutta M，et al. Lipid metabolism and lipophagy in cancer［J］. Biochem Biophys Res Commun，2018，504（3）：582-589.
[6]	Koundouros N，Poulogiannis G. Reprogramming of fatty acid metabolism in cancer［J］. Br J Cancer，2020，122（1）：4-22.
[7]	Ma Y，Temkin SM，Hawkridge AM，et al. Fatty acid oxidation：An emerging facet of metabolic transformation in cancer［J］. Cancer Lett，2018，435：92-100.
[8]	Wang Q，Li D，Cao G，et al. IL-27 signaling promotes adipocyte thermogenesis and energy expenditure［J］. Nature，2021，600（7888）：314-318.
[9]	Kir S，Spiegelman BM. CACHEXIA & BROWN FAT：A BURNING ISSUE IN CANCER［J］. Trends Cancer，2016，2（9）：461-463.
[10]	Kir S，White JP，Kleiner S，et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia［J］. Nature，2014，513（7516）：100-104.
[11]	Argilés JM. The 2015 ESPEN Sir David Cuthbertson lecture：Inflammation as the driving force of muscle wasting in cancer［J］. Clin Nutr，2017，36（3）：798-803.
[12]	Archid R，Solass W，Tempfer C，et al. Cachexia Anorexia Syndrome and Associated Metabolic Dysfunction in Peritoneal Metastasis［J］. Int J Mol Sci，2019，20（21）：5444.
[13]	Fukawa T，Yan-Jiang BC，Min-Wen JC，et al. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia［J］. Nat Med，2016，22（6）：666-671.
[14]	Lu S，Wang Y. Nonmetabolic functions of metabolic enzymes in cancer development［J］. Cancer Communication（London），2018，38（1）：63.
[15]	Fearon KC，Glass DJ，Guttridge DC. Cancer cachexia：mediators，signaling，and metabolic pathways［J］. Cell Metabolism，2012，16（2）：153-166.
[16]	Riuzzi F，Sorci G，Sagheddu R，et al. RAGE in the pathophysiology of skeletal muscle［J］. J Cachexia Sarcopenia Muscle，2018，9（7）：1213-1234.
[17]	Li Z，Zhang H. Reprogramming of glucose，fatty acid and amino acid metabolism for cancer progression［J］. Cell Mol Life Sci，2016，73（2）：377-392.
[18]	Hao JW，Wang J，Guo H，et al. CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis［J］. Nat Commun，2020，11（1）：4765.
[19]	Pascual G，Avgustinova A，Mejetta S，et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36［J］. Nature，2017，541（7635）：41-45.
[20]	Calvo D，Gómez-Coronado D，Suárez Y，et al. Human CD36 is a high affinity receptor for the native lipoproteins HDL，LDL，and VLDL［J］. J Lipid Res，1998，39（4）：777-788.

Please choose a citation manager

Content to export